During the past decade, Tungs' Taichung Metroharbour Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tungs' Taichung Metroharbour Hospital" #1 sponsor was "Tungs' Taichung Metroharbour Hospital" with 10 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Chang Gung Memorial Hospital" with 1 trials sponsored and "Conmed Pharmaceutical & Bio-Medical Corporation" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tungs' Taichung Metroharbour Hospital" #1 collaborator was "Chang Gung Memorial Hospital" with 1 trials as a collaborator, "Fu Jen Catholic University" with 1 trials as a collaborator, "Kaohsiung Medical University" with 1 trials as a collaborator, "Taichung Tzu Chi Hospital" with 1 trials as a collaborator and "Taichung Veterans General Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Tungs' Taichung Metroharbour Hospital" are "Sarcopenia" (3 trials), "Constipation" (2 trials), "Inflammation" (2 trials), "Atrial Fibrillation" (1 trials) and "Autophagy" (1 trials). Many other conditions were trialed in "Tungs' Taichung Metroharbour Hospital" in a lesser frequency.

Most popular intervention types in "Tungs' Taichung Metroharbour Hospital" are "Drug" (5 trials), "Other" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Niraparib" (2 trials), "Prednisone" (2 trials), "AST-120" (1 trials) and "Abiraterone Acetate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tungs' Taichung Metroharbour Hospital" are 14 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Tungs' Taichung Metroharbour Hospital". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Tungs' Taichung Metroharbour Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tungs' Taichung Metroharbour Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".